Trial Details

TERMINATED
Basic Information
Clinical ID c1803
Identifier NCT02403323
Trial Title Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Crohn Disease
Interventions DRUG: Etrolizumab
Participant Information
Sponsor Hoffmann-La Roche
City Arcadia
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2015-06-08
Primary Completion Date 2023-10-09
Completion Date 2023-10-09